Decreased Cardiac NOX4 and SIRT-1 Protein Levels Contribute to Decreased Angiogenesis in the Heart of Diabetic Rats:

Shiva Roshan Milani1,2, Bagher Pourheydar3,2, Saman Daneshfar4

  • 1Department of Physiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Insights

Diabetes reduces heart angiogenesis by decreasing NOX4 and SIRT-1. Insulin-like growth factor 1 (IGF-1) and exercise therapy restored these levels, improving heart health in diabetic rats.

Area of Science:

  • Cardiovascular Research
  • Metabolic Disease Research
  • Molecular Biology

Background:

  • Reduced heart angiogenesis is a key risk factor for heart disease in diabetes.
  • NADPH oxidase 4 (NOX4) and sirtuin 1 (SIRT-1) are critical angiogenesis mediators.
  • Understanding their role in diabetic cardiomyopathy is crucial for therapeutic development.

Purpose of the Study:

  • To investigate changes in NOX4 and SIRT-1 protein levels in the hearts of diabetic rats.
  • To evaluate the impact of Insulin-like Growth Factor 1 (IGF-1) and exercise on these mediators.
  • To assess the combined effect of IGF-1 and exercise on angiogenesis in diabetic hearts.

Main Methods:

  • Type 1 diabetes was induced in male Wistar rats using streptozotocin.
  • Angiogenesis was assessed via PECAM-1/CD31 immunostaining.
  • NOX4 and SIRT-1 expression levels were quantified using ELISA.

Main Results:

  • Diabetic rats showed increased HbA1c, decreased SIRT-1, NOX4 levels, and reduced angiogenesis.
  • IGF-1 and exercise interventions, individually or combined, reversed these diabetes-induced changes.
  • A synergistic effect was observed for IGF-1 and exercise on SIRT-1, HbA1c, and angiogenesis.

Conclusions:

  • Downregulation of NOX4 and SIRT-1 protein levels may mediate reduced cardiac angiogenesis in diabetes.
  • IGF-1 and exercise represent potential therapeutic strategies to increase NOX4 and SIRT-1 levels in diabetic rat hearts.
  • Combined IGF-1 and exercise therapy demonstrates a potent synergistic effect for improving cardiac angiogenesis in diabetes.